Loading...
•
Jun 30, 2022
Cencora Q3 2022 Earnings Report
AmerisourceBergen's revenue increased by 12.5% year-over-year, with GAAP diluted EPS of $1.92 and adjusted diluted EPS of $2.62.
Key Takeaways
AmerisourceBergen reported a strong third quarter with revenue increasing by 12.5% year-over-year to $60.1 billion. The company raised its full year outlook for adjusted diluted EPS to a range of $10.90 to $11.10.
Revenue increased 12.5 percent year-over-year to $60.1 billion.
GAAP diluted EPS was $1.92, compared to $1.40 in the prior year quarter.
Adjusted diluted EPS increased 21.3 percent to $2.62 from $2.16 in the prior year quarter.
Adjusted diluted EPS guidance has been raised to a range of $10.90 to $11.10 for fiscal year 2022.
Cencora
Cencora
Forward Guidance
AmerisourceBergen is updating its fiscal year 2022 financial guidance to reflect the stronger than expected performance of several of its businesses and a lower average diluted share count.
Positive Outlook
- Adjusted Diluted Earnings Per Share to be in the range of $10.90 to $11.10, raised from the previous range of $10.80 to $11.05.
- U.S. Healthcare Solutions operating income to be in the range of $2.44 billion to $2.48 billion, representing growth of 8% to 10%, raising the lower end of the previous range of $2.42 billion to $2.48 billion
- Weighted average diluted shares to be in the range of 211 million to 211.5 million shares for the fiscal year, lowered from the previous range of approximately 212 million shares
- Adjusted free cash flow to be in the range of $2.3 billion to $2.5 billion, raising the lower end of the previous range of $2.0 billion to $2.5 billion.
- All other previously communicated aspects of the Company's fiscal year 2022 financial guidance and assumptions remain the same.